Center-Authored Papers

Filters: Author is Gotlib, Jason  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
2009
O'Brien S, Berman E, Borghaei H, DeAngelo DJ, DeVetten MP, Devine S, Erba HP, Gotlib J, Jagasia M, Moore JO et al..  2009.  NCCN clinical practice guidelines in oncology: chronic myelogenous leukemia.. Journal of the National Comprehensive Cancer Network : JNCCN. 7(9):984-1023.
2013
O'Brien S, Radich JP, Abboud CN, Akhtari M, Altman JK, Berman E, DeAngelo DJ, Deininger M, Devine S, Fathi AT et al..  2013.  Chronic Myelogenous Leukemia, Version 1.2014.. Journal of the National Comprehensive Cancer Network : JNCCN. 11(11):1327-40. Abstract
2014
Gupta V, Gotlib J, Radich JP, Kröger NM, Rondelli D, Verstovsek S, Deeg HJ.  2014.  JAK Inhibitors and Allogeneic Stem Cell Transplantation for Myelofibrosis.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
Antineoplastic Agents
O'Brien S, Berman E, Borghaei H, DeAngelo DJ, DeVetten MP, Devine S, Erba HP, Gotlib J, Jagasia M, Moore JO et al..  2009.  NCCN clinical practice guidelines in oncology: chronic myelogenous leukemia.. Journal of the National Comprehensive Cancer Network : JNCCN. 7(9):984-1023.
April 2014
Gupta V, Gotlib J, Radich JP, Kröger NM, Rondelli D, Verstovsek S, Deeg HJ.  2014.  JAK Inhibitors and Allogeneic Stem Cell Transplantation for Myelofibrosis.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
Clinical Research Division
O'Brien S, Radich JP, Abboud CN, Akhtari M, Altman JK, Berman E, DeAngelo DJ, Deininger M, Devine S, Fathi AT et al..  2013.  Chronic Myelogenous Leukemia, Version 1.2014.. Journal of the National Comprehensive Cancer Network : JNCCN. 11(11):1327-40. Abstract
O'Brien S, Berman E, Borghaei H, DeAngelo DJ, DeVetten MP, Devine S, Erba HP, Gotlib J, Jagasia M, Moore JO et al..  2009.  NCCN clinical practice guidelines in oncology: chronic myelogenous leukemia.. Journal of the National Comprehensive Cancer Network : JNCCN. 7(9):984-1023.
Gupta V, Gotlib J, Radich JP, Kröger NM, Rondelli D, Verstovsek S, Deeg HJ.  2014.  JAK Inhibitors and Allogeneic Stem Cell Transplantation for Myelofibrosis.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
hematopoietic stem cell transplantation
O'Brien S, Berman E, Borghaei H, DeAngelo DJ, DeVetten MP, Devine S, Erba HP, Gotlib J, Jagasia M, Moore JO et al..  2009.  NCCN clinical practice guidelines in oncology: chronic myelogenous leukemia.. Journal of the National Comprehensive Cancer Network : JNCCN. 7(9):984-1023.
Humans
O'Brien S, Berman E, Borghaei H, DeAngelo DJ, DeVetten MP, Devine S, Erba HP, Gotlib J, Jagasia M, Moore JO et al..  2009.  NCCN clinical practice guidelines in oncology: chronic myelogenous leukemia.. Journal of the National Comprehensive Cancer Network : JNCCN. 7(9):984-1023.
July 2014
O'Brien S, Radich JP, Abboud CN, Akhtari M, Altman JK, Berman E, DeAngelo DJ, Deininger M, Devine S, Fathi AT et al..  2013.  Chronic Myelogenous Leukemia, Version 1.2014.. Journal of the National Comprehensive Cancer Network : JNCCN. 11(11):1327-40. Abstract
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
O'Brien S, Berman E, Borghaei H, DeAngelo DJ, DeVetten MP, Devine S, Erba HP, Gotlib J, Jagasia M, Moore JO et al..  2009.  NCCN clinical practice guidelines in oncology: chronic myelogenous leukemia.. Journal of the National Comprehensive Cancer Network : JNCCN. 7(9):984-1023.